A real-life study assessing the efficacy of single capsule Bismuth quadruple therapy supplemented with probiotics for H pylori eradication in patients naive to treatment in a high clarithromycin resistance area

被引：0
|
作者：
Priadko, K. [1 ,2 ]
Gravina, A. G. [1 ]
Granata, L. [1 ]
Cerbone, R. [1 ]
Ciamarra, P. [1 ]
Montanaro, A. [1 ]
Facchiano, A. [1 ]
Miranda, A. [1 ]
Romano, M. [1 ]
机构：
[1] Univ Campania L Vanvitelli, Naples, Italy
[2] Dnipro State Med Acad, Dnipro, Ukraine
来源：
HELICOBACTER | 2020年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
EP2.41
引用
收藏
页码：44 / 44
页数：1
相关论文
共 20 条
  • [1] Single Capsule Bismuth Quadruple Therapy for Eradication of H. pylori Infection: A Real-Life Study
    Gravina, Antonietta G.
    Priadko, Kateryna
    Granata, Lucia
    Facchiano, Angela
    Scida, Giuseppe
    Cerbone, Rosa
    Ciamarra, Paola
    Romano, Marco
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [2] A real life study of Helicobacter pylori eradication with bismuth quadruple therapy in naive and previously treated patients
    Jose Gomez-Rodriguez, Blas
    Castro-Laria, Luisa
    Arguelles-Arias, Federico
    Castro-Marquez, Cristina
    Caunedo-Alvarez, Angel
    Romero-Gomez, Manuel
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (08) : 552 - 557
  • [3] Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study
    Romano, Marco
    Gravina, Antonietta Gerarda
    Nardone, Gerardo
    Federico, Alessandro
    Dallio, Marcello
    Martorano, Marco
    Mucherino, Caterina
    Romiti, Alessandra
    Avallone, Luciana
    Granata, Lucia
    Priadko, Katerina
    Compare, Debora
    Tuccillo, Concetta
    Romito, Maria Raffaella
    Sgambato, Dolores
    Miranda, Agnese
    Romano, Lorenzo
    Loguercio, Carmelina
    Bazzoli, Franco
    Zagari, Rocco Maurizio
    [J]. HELICOBACTER, 2020, 25 (04)
  • [4] A multi-center real-life study on comparison between bismuth quadruple (BQ) (10 days) and clarithromycin (CLA) containing non-bismuth quadruple (CT) therapy (10 and 14 days) in the eradication of H. pylori infection in patients naive to treatment in a region with high CLA and dual resistance
    Gravina, A. G.
    Zagari, R. M.
    Nardone, G.
    Federico, A.
    Dallio, M.
    Martorano, M.
    Mucherino, C.
    Romiti, A.
    Avallone, L.
    Granata, L.
    Colacino, L.
    Facchiano, A.
    Picascia, D.
    Sgambato, D.
    Miranda, A.
    Romano, L.
    Loguercio, C.
    Romano, M.
    [J]. HELICOBACTER, 2019, 24
  • [5] A Real Life Observational Study on the eradication of H. pylori infection in patients naive to treatment using concomitant therapy or bismuth quadruple therapy(three-in-one pill)
    Gravina, A. G.
    Nardone, G.
    Miranda, A.
    Sgambato, D.
    Rocco, A.
    Visciola, G.
    Tuccillo, C.
    Compare, D.
    Dallio, M.
    Granata, L.
    Romano, L.
    Romito, R.
    Priadko, E.
    Martorano, M.
    Mucherino, C.
    Rocco, P.
    Federico, A.
    Loguercio, C.
    Romano, M.
    [J]. HELICOBACTER, 2017, 22
  • [6] A REAL LIFE OBSERVATIONAL STUDY ON THE ERADICATION OF H. PYLORI INFECTION IN PATIENTS NAIVE TO TREATMENT USING CONCOMITANT THERAPY OR BISMUTH QUADRUPLE THERAPY (THREE-IN-ONE PILL)
    Gravina, A. G.
    Nardone, G.
    Miranda, A.
    Sgambato, D.
    Rocco, A.
    Visciola, G.
    Tuccillo, C.
    Compare, D.
    Dallio, M.
    Granata, L.
    Romano, L.
    De Luca, G.
    Romito, R.
    Martorano, M.
    Mucherino, C.
    Rocco, P.
    Federico, A.
    Loguercio, C.
    Romano, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E126 - E127
  • [7] Efficacy of Non-Bismuth Quadruple "Concomitant" Therapy for H-pylori Infection in a Setting With High Clarithromycin Resistance
    Molina-Infante, Javier
    Pazos-Pacheco, Maria del Carmen
    Gallardo, Belen Perez
    Rodrigues, Gema Vinagre
    Alonso, Moises Hernandez
    Duenas, Carmen
    Gonzalez-Garcia, Guadalupe
    Rodriguez, Jose M. Mateos
    Bermejo, Miguel Fernandez
    Gisbert, Javier P.
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S880 - S880
  • [8] Effectiveness and safety of bismuth quadruple therapy (Pylera®) in combination with PPIs for the eradication of H. pylori infection in patients with dual clarithromycin and metronidazole resistance
    Fiorini, G.
    Saracino, I. M.
    Gatta, L.
    Vaira, D.
    [J]. HELICOBACTER, 2017, 22
  • [9] Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial)
    Tungtrongchitr, Nuttapat
    Bongkotvirawan, Phubordee
    Ratana-Amornpin, Sarita
    Siramolpiwat, Sith
    Eiamsitrakoon, Thanee
    Gamnarai, Pornpen
    Wongcha-um, Arti
    Yamaoka, Yoshio
    Pawa, Kammal Kumar
    Vilaichone, Ratha-korn
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [10] High efficacy of 14-day high-dose PPI bismuth-containing quadruple therapy with probiotics supplement for Helicobacter pylori eradication in high clarithromycin resistance areas: A double blinded-randomized placebo-controlled study
    Poonyam, P.
    Vilaichone, R.
    Chotivitayatarakorn, P.
    Mahachai, V.
    [J]. HELICOBACTER, 2019, 24
12